These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8440768)

  • 1. Evaluation of the pharmacokinetics and tolerability of tirilazad mesylate, a 21-aminosteroid free radical scavenger: II. Multiple-dose administration.
    Fleishaker JC; Peters GR; Cathcart KS; Steenwyk RC
    J Clin Pharmacol; 1993 Feb; 33(2):182-90. PubMed ID: 8440768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the pharmacokinetics and tolerability of tirilazad mesylate, a 21-aminosteroid free radical scavenger: I. Single-dose administration.
    Fleishaker JC; Peters GR; Cathcart KS
    J Clin Pharmacol; 1993 Feb; 33(2):175-81. PubMed ID: 8382708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple-dose tolerability and pharmacokinetics of tirilazad mesylate at doses of up to 10 mg/kg/day administered over 5-10 days in healthy volunteers.
    Fleishaker JC; Hulst LK; Peters GR
    Int J Clin Pharmacol Ther; 1994 May; 32(5):223-30. PubMed ID: 7921515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part I. A cooperative study in Europe, Australia, New Zealand, and South Africa.
    Lanzino G; Kassell NF; Dorsch NW; Pasqualin A; Brandt L; Schmiedek P; Truskowski LL; Alves WM
    J Neurosurg; 1999 Jun; 90(6):1011-7. PubMed ID: 10350245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender does not affect the degree of induction of tirilazad clearance by phenobarbital.
    Fleishaker JC; Pearson LK; Peters GR
    Eur J Clin Pharmacol; 1996; 50(1-2):139-45. PubMed ID: 8739825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety study of tirilazad mesylate in patients with acute ischemic stroke (STIPAS).
    STIPAS Investigators
    Stroke; 1994 Feb; 25(2):418-23. PubMed ID: 8303754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of tirilazad in healthy male subjects at doses above 6 mg/kg/day.
    Fleishaker JC; Peters GR
    Int J Clin Pharmacol Ther; 1997 Jan; 35(1):28-32. PubMed ID: 9021439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand.
    Kassell NF; Haley EC; Apperson-Hansen C; Alves WM
    J Neurosurg; 1996 Feb; 84(2):221-8. PubMed ID: 8592224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II trial of tirilazad in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study.
    Haley EC; Kassell NF; Alves WM; Weir BK; Hansen CA
    J Neurosurg; 1995 May; 82(5):786-90. PubMed ID: 7714603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America.
    Haley EC; Kassell NF; Apperson-Hansen C; Maile MH; Alves WM
    J Neurosurg; 1997 Mar; 86(3):467-74. PubMed ID: 9046304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of a pharmacokinetic/pharmacodynamic interaction between nimodipine and tirilazad mesylate in healthy volunteers.
    Fleishaker JC; Hulst LK; Peters GR
    J Clin Pharmacol; 1994 Aug; 34(8):837-41. PubMed ID: 7962672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of phenytoin on the pharmacokinetics of tirilazad mesylate in healthy male volunteers.
    Fleishaker JC; Hulst LK; Peters GR
    Clin Pharmacol Ther; 1994 Oct; 56(4):389-97. PubMed ID: 7955800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of age and gender on tirilazad pharmacokinetics in humans.
    Hulst LK; Fleishaker JC; Peters GR; Harry JD; Wright DM; Ward P
    Clin Pharmacol Ther; 1994 Apr; 55(4):378-84. PubMed ID: 8162663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part II. A cooperative study in North America.
    Lanzino G; Kassell NF
    J Neurosurg; 1999 Jun; 90(6):1018-24. PubMed ID: 10350246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of endotoxin on tirilazad mesylate (U74006F) pharmacokinetic parameters in neonatal calves.
    Rose ML; Semrad SD; Putnam ML; Brown SA
    J Vet Pharmacol Ther; 1993 Dec; 16(4):438-45. PubMed ID: 8126760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of tirilazad mesylate (U74006F) on cerebral oxygen consumption, and reactivity of cerebral blood flow to carbon dioxide in healthy volunteers.
    Olsen KS; Videbaek C; Agerlin N; Krøll M; Bøge-Rasmussen T; Paulson OB; Gjerris F
    Anesthesiology; 1993 Oct; 79(4):666-71. PubMed ID: 8214745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the pharmacokinetics of tirilazad mesylate in healthy volunteers and stable subjects with mild liver cirrhosis.
    Pearson LK; Fleishaker JC; Peters GR
    Eur J Clin Pharmacol; 1996; 50(4):299-304. PubMed ID: 8803523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the 21-aminosteroid tirilazad mesylate on leukocyte adhesion and macromolecular leakage during endotoxemia.
    Schmidt H; Schmidt W; Müller T; Böhrer H; Bach A; Gebhard MM; Martin E
    Surgery; 1997 Mar; 121(3):328-34. PubMed ID: 9068675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limiting ischemic spinal cord injury using a free radical scavenger 21-aminosteroid and/or cerebrospinal fluid drainage.
    Francel PC; Long BA; Malik JM; Tribble C; Jane JA; Kron IL
    J Neurosurg; 1993 Nov; 79(5):742-51. PubMed ID: 8410254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of tirilazad and U-89678 in ischemic stroke patients receiving a loading regimen and maintenance regimen of 10 mg/kg/day of tirilazad.
    Fleishaker JC; Peters GR
    J Clin Pharmacol; 1996 Sep; 36(9):809-13. PubMed ID: 8889901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.